The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomized, double-blind, phase III trial comparing denosumab biosimilar QL1206 and denosumab in patients with bone metastases from solid tumors.
 
Huiping Li
No Relationships to Disclose
 
Yan Huang
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - AstraZeneca; Innovent Biologics
Speakers' Bureau - AstraZeneca; BeiGene; HenRui; Innovent Biologics; Roche China
Research Funding - Akeso Biopharma (Inst); AstraZeneca (Inst); BMS (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); Junshi Pharmaceuticals (Inst); QiLu Pharmaceutical (Inst)
 
Zhendong Chen
No Relationships to Disclose
 
Aiping Zeng
No Relationships to Disclose
 
Helong Zhang
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Shihong Wei
No Relationships to Disclose
 
Qingshan Li
No Relationships to Disclose
 
Xiaojia Wang
No Relationships to Disclose
 
Xiangcai Wang
No Relationships to Disclose
 
Xiuwen Wang
No Relationships to Disclose
 
Runxiang Yang
No Relationships to Disclose
 
Xiumei Dai
No Relationships to Disclose
 
Minghong Bi
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Cuicui Han
Employment - QiLu Pharmaceutical
 
Qianqian Liu
Employment - QiLu Pharmaceutical
 
Yujie Li
Employment - QiLu Pharmaceutical